Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00022964
DRKS00022964
Completed
Not Applicable

Investigation of clinical characteristics, management and outcome of ARDS patients: a Germany-wide register study DIVI ECMO COVID-19 Register - DIVI ECMO COVID Register

Klinik für Anästhesiologie, Universitätsklinikum Würzburg (UKW)0 sites1,300 target enrollmentSeptember 7, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCOVID-19 induced ARDSIntensive care unit treatment (participation in DIVI ECMO COVID Register) ECMO therapy during intensive careJ80U07.1U99.0J12.8Z11Z20.8Adult respiratory distress syndromeCOVID-19, virus identifiedOther viral pneumoniaSpecial screening examination for infectious and parasitic diseasesContact with and exposure to other communicable diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19 induced ARDSIntensive care unit treatment (participation in DIVI ECMO COVID Register) ECMO therapy during intensive care
Sponsor
Klinik für Anästhesiologie, Universitätsklinikum Würzburg (UKW)
Enrollment
1300
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 7, 2020
End Date
January 31, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik für Anästhesiologie, Universitätsklinikum Würzburg (UKW)

Eligibility Criteria

Inclusion Criteria

  • •COVID\-19 induced ARDS
  • •Intensive care unit treatment (participation in DIVI ECMO COVID Register)
  • •ECMO therapy during intensive care

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A study to compare Indian heart failure patients with and without diabetes
CTRI/2017/07/009069Cipla2,500
Not yet recruiting
Not Applicable
Multicentric study on outcome of treatment of osteosarcoma in India, conducted by Indian Musculo Skeletal Oncology Society
CTRI/2023/05/053100Indian Musculo Skeletal Oncology Society (IMSOS)
Completed
Not Applicable
Clinical study to investigate the characteristics of symptom recurrence after discontinuing treatment compared to continuation of treatment in patients with Irritable Bowel Syndrome with constipation (C-IBS) who responded favorably to treatment with tegaserod, a partial agonist of the 5-HT4 receptor-K589 Irritable bowel syndrome without diarrhoeaIrritable bowel syndrome without diarrhoeaK589
PER-016-01OVARTIS BIOSCIENSES PERU S.A.,
Not yet recruiting
Not Applicable
A study on the clinical characteristics including severity of pulmonary fibrosis by COVID-19Certain infectious and parasitic diseases
KCT0006312Asan Medical Center100
Recruiting
Not Applicable
Translational Research of Inflammatory Bowel Disease in KoreaDiseases of the digestive system
KCT0000545Asan Medical Center7,500